A review on ochratoxin A transcriptomic studies

Food and Chemical Toxicology

Volumn 59, Issue , 2013, Pages 766-783

  Vettorazzi, Ariane ^a   van Delft, Joost ^b   López de Cerain, Adela ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Gene expression; Microarrays; Mycotoxin; Ochratoxin A; Toxicogenomics; Transcriptomics

Indexed keywords

ALPHA 2 MACROGLOBULIN; CILIARY NEUROTROPHIC FACTOR; CONTRAPSIN; CONTRAPSIN LIKE PROTEASE INHIBITOR; CYTOCHROME P450; FIBRINOGEN; KIDNEY INJURY MOLECULE 1; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; OCHRATOXIN; PHENYLALANINE TRANSFER RNA LIGASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEINASE INHIBITOR; REGUCALCIN; STRESS ACTIVATED PROTEIN KINASE; THROMBOPLASTIN; TUBERIN; UNCLASSIFIED DRUG; WNT PROTEIN; ZINC FINGER PROTEIN;

ACUTE PHASE RESPONSE; APOPTOSIS; CALCIUM HOMEOSTASIS; CARCINOGENESIS; CELL COMMUNICATION; CELL DIVISION; CELL INTERACTION; CELL PROLIFERATION; CELL SURVIVAL; CYTOSKELETON; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DAMAGE; DNA DAMAGE RESPONSE GENE; DNA REPAIR; DOWN REGULATION; ENZYME ACTIVATION; GAP JUNCTION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC REGULATION; GENOTOXICITY; KIDNEY INJURY; NEPHROTOXICITY; NONHUMAN; ONCOGENE C MYC; OXIDATIVE STRESS; PROTEIN SYNTHESIS INHIBITION; REVIEW; TOXICOKINETICS; TOXIN ANALYSIS; TRANSCRIPTOMICS; UPREGULATION; XENOBIOTIC METABOLISM;

AVENA; RATTUS;

GENE EXPRESSION; MICROARRAYS; MYCOTOXIN; OCHRATOXIN A; TOXICOGENOMICS; TRANSCRIPTOMICS;

ANIMALS; CARCINOGENS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY; KIDNEY NEOPLASMS; MYCOTOXINS; NEOPLASM PROTEINS; OCHRATOXINS; TRANSCRIPTOME;

EID: 84882692410     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2013.05.043     Document Type: Review

References (118)

1. Abnet C.C. Carcinogenic food contaminants. Cancer Invest. 2007, 25:189-196.
2. Afshari C.A., Nuwaysir E.F., Barrett J.C. Application of complementary DNA microarray technology to carcinogen identification, toxicology and drug safety evaluation. Cancer Res. 1999, 59:4759-4760.
3. Alvarez L., Gil A.G., Ezpeleta O., Garcia-Jalon J.A., Lopez de Cerain A. Immunotoxic effects of Ochratoxin A in Wistar rats after oral administration. Food Chem. Toxicol. 2004, 42:825-834.
4. Alvarez-Erviti L., Leache C., Gonzalez-Peñas E., Lopez de Cerain A.L. Alterations induced in vitro by ochratoxin A in rat lymphoid cells. Hum. Exp. Toxicol. 2005, 24:459-466.
5. Anzai N., Jutabha P., Endou H. Molecular mechanism of ochratoxin a transport in the kidney. Toxins 2010, 2:1381-1398.
6. Arbillaga L., Ezpeleta O., Lopez de Cerain A. ¿Es la ocratoxina A una micotoxina mutagénica?. Rev. Toxicol. 2004, 21:1-10.
7. Arbillaga L., Azqueta A., van Delft J.H., Lopez de Cerain A. In vitro gene expression data supporting a DNA non-reactive genotoxic mechanism for ochratoxin A. Toxicol. Appl. Pharmacol. 2007, 220:216-224.
8. Arbillaga L., Vettorazzi A., Gil A.G., van Delft J.H., Garcia-Jalon J.A., Lopez de Cerain A. Gene expression changes induced by ochratoxin A in renal and hepatic tissues of male F344 rat after oral repeated administration. Toxicol. Appl. Pharmacol. 2008, 230:197-207.
9. Barlow S., Schlatter J. Risk assessment of carcinogens in food. Toxicol. Appl. Pharmacol. 2010, 243:180-190.
10. Beard S.E., Capaldi S.R., Gee P. Stress responses to DNA damaging agents in the human colon carcinoma cell line, RKO. Mutat. Res. 1996, 371:1-13.
11. Bendele A.M., Carlton W.W., Krogh P., Lillehoj E.B. Ochratoxin A carcinogenesis in the (C57BL/6J X C3H)F1 mouse. J. Natl. Cancer Inst. 1985, 75:733-742.
12. Bennett J.W., Klich M. Mycotoxins. Clin. Microbiol. Rev. 2003, 16:497-516.
13. Bolt H.M., Foth H., Hengstler J.G., Degen G.H. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective. Toxicol. Lett. 2004, 151:29-41.
14. Bösch-Saadatmandi C., Hundhausen C., Jofre-Monseny L., Blank R., Wolffram S., Rimbach G. Ochratoxin A-induced cytotoxicity in liver (HepG2) cells: Impact of serum concentration, dietary antioxidants and glutathione-modulating compounds. J Appl. Bot. Food Qual. 2006, 80:179-186.
15. Boudra H., Le Bars P., Le Bars J. Thermostability of ochratoxin A in wheat under two moisture conditions. Appl. Environ. Microbiol. 1995, 61:1156-1158.
16. Bräse S., Encinas A., Keck J., Nising C. Chemistry and biology of mycotoxins and related fungal metabolites. Chem. Rev. 2009, 109:3903-3990.
17. Castegnaro M., Mohr U., Pfohl-Leszkowicz A., Esteve J., Steinmann J., Tillmann T., Michelon J., Bartsch H. Sex- and strain-specific induction of renal tumors by ochratoxin A in rats correlates with DNA adduction. Int. J. Cancer 1998, 77:70-75.
18. Cavin C., Delatour T., Marin-Kuan M., Holzhuser D., Higgins L., Bezenon C., Guignard G., Junod S., Richoz-Payot J., Gremaud E., Hayes J., Nestler S., Mantle P., Schilter B. Reduction in antioxidant defenses may contribute to ochratoxin A toxicity and carcinogenicity. Toxicol. Sci. 2007, 96:30-39.
19. Clapham D.E. Calcium signaling. Cell 2007, 131:1047-1058.
20. Commission Regulation (EC) No 1126/2007 of 28 September 2007 amending Regulation (EC) No 1881/2006 setting maximum levels for certain contaminants in foodstuffs as regards fusarium toxins in maize and maize products.
21. Commission Regulation (EC) No 1881/2006 of 19 December 2006 setting maximum levels for certain contaminants in foodstuffs.
22. Commission Regulation (EU) No 105/2010 of 5 February 2010 amending Regulation (EC) No 1881/2006 setting maximum levels for certain contaminants in foodstuffs as regards ochratoxin A.
23. Commission Regulation (EU) No 1058/2012 of 12 November 2012 amending Regulation (EC) No 1881/2006 as regards maximum levels for aflatoxins in dried figs.
24. Commission Regulation (EU) No 165/2010 of 26 February 2010 amending Regulation (EC) No 1881/2006 setting maximum levels for certain contaminants in foodstuffs as regards aflatoxins.
25. Commission Regulation (EU) No 594/2012 of 5 July 2012 amending Regulation (EC) 1881/2006 as regards the maximum levels of the contaminants ochratoxin a, non dioxin-like PCBs and melamine in foodstuffs.
26. Creppy E.E., Stormer F.C., Kern D., Roschenthaler R., Dirheimer G. Effects of ochratoxin A metabolites on yeast phenylalanyl-tRNA synthetase and on the growth and in vivo protein synthesis of hepatoma cells. Chem. Biol. Interact. 1983, 47:239-247.
27. Cui Y., Paules R.S. Use of transcriptomics in understanding mechanisms of drug-induced toxicity. Pharmacogenomics 2010, 11:573-585.
28. Dickinson D.A., Warners G.R., Quievryn G., Messer J., Zhitkovich A., Rubitski E., Aubrecht J. Differentiation of DNA reactive and nonreactive genotoxic mechanisms using gene expression profile analysis. Mutat. Res. 2004, 549:29-41.
29. Dietrich D.R., Swenberg J.A. Preneoplastic lesions in rodent kidney induced spontaneously or by non-genotoxic agents: predictive nature and comparison to lesions induced by genotoxic carcinogens. Mutat Res. 1991, 248:239-260.
30. Dietrich D.R., O'Brien E., Stack M.E., Heussner A.H. Species- and sex-specific renal cytotoxicity of ochratoxin A and B in vitro. Exp. Toxicol. Pathol. 2001, 53:215-225.
31. Dietrich D.R., Heussner A.H., O'Brien E. Ochratoxin A: comparative pharmacokinetics and toxicological implications (experimental and domestic animals and humans). Food Addit. Contam. 2005, 22(Suppl 1):45-52.
32. Doktorova T.Y., Ellinger-Ziegelbauer H., Vinken M., Vanhaecke T., van Delft J., Kleinjans J., Ahr H.J., Rogiers V. Comparison of hepatocarcinogen-induced gene expression profiles in conventional primary rat hepatocytes with in vivo rat liver. Arch Toxicol. 2012, 86:1399-1411.
33. Dortant P.M., Peters-Volleberg G.W., Van Loveren H., Marquardt R.R., Speijers G.J. Age-related differences in the toxicity of ochratoxin A in female rats. Food Chem. Toxicol. 2001, 39:55-65.
34. EC (European Community), 1998. Opinion of the Scientific Committee on Food (SCF) on ochratoxin A. Expressed on 17 September 1998.
35. EC (European Community), 2002. Task 3.2.7: Assessment of dietary intake of ochratoxin A by the population of EU Members States. European Commission, Directorate General Health and Consumer Protection January (Reports on Tasks for Scientific Cooperation).
36. EFSA (European Food Safety Authority) Opinion of the Scientific Panel on contaminants in the food chain on a request from the Commission related to ochratoxin A in food. EFSA J. 2006, 365:1-56. Adopted on 4 April 2006.
37. EFSA (European Food Safety Authority) Opinion of the scientific panel on contaminants in the food chain related to the potential increase of consumer health risk by a possible increase of the existing maximum levels for aflatoxins in almonds, hazelnuts and pistachios and derived products. EFSA J. 2007, 446:1-127. (Adopted on 25 January 2007).
38. Ellinger-Ziegelbauer H., Aubrecht J., Kleinjans J.C., Ahr H.J. Application of toxicogenomics to study mechanisms of genotoxicity and carcinogenicity. Toxicol. Lett. 2009, 186:36-44.
39. FAO (Food and Agriculture Organization of the United Nations), 2001. Manual on the application of the HACCP system in mycotoxin prevention and control. FAO Food and Nutrition Paper, No 73.
40. FAO (Food and Agriculture Organization of the United Nations), 2003. Worldwide regulations for mycotoxins in food and feed in 2003. FAO Food and Nutrition Paper, No 81.
41. Gatzidou E.T., Zira A.N., Theocharis S.E. Toxicogenomics: a pivotal piece in the puzzle of toxicological research. J. Appl. Toxicol. 2007, 27:302-309.
42. Gekle M., Schwerdt G., Freudinger R., Mildenberger S., Wilflingseder D., Pollack V., Dander M., Schramek H. Ochratoxin A induces JNK activation and apoptosis in MDCK-C7 cells at nanomolar concentrations. J. Pharmacol. Exp. Ther. 2000, 293:837-844.
43. Gekle M., Sauvant C., Schwerdt G. Ochratoxin A at nanomolar concentrations: a signal modulator in renal cells. Mol. Nutr. Food Res. 2005, 49:118-130.
44. Gennari A., Pazos P., Boveri M., Callaghan R., Casado J., Maurici D., Corsini E., Prieto P. New insights into the mechanisms involved in renal proximal tubular damage induced in vitro by ochratoxin A. J. Biochem. Mol. Toxicol. 2004, 18:43-49.
45. Guma M., Firestein G.S. C-Jun N-Terminal Kinase in Inflammation and Rheumatic Diseases. Open Rheumatol J. 2012, 6:220-231.
46. Hagelberg S., Hult K., Fuchs R. Toxicokinetics of ochratoxin A in several species and its plasma-binding properties. J. Appl. Toxicol. 1989, 9:91-96.
47. Haighton L.A., Lynch B.S., Magnuson B.A., Nestmann E.R. A reassessment of risk associated with dietary intake of ochratoxin A based on a lifetime exposure model. Crit Rev Toxicol. 2012, 42:147-168.
48. Hamadeh H.K., Bushel P.R., Jayadev S. Gene expression analysis reveals chemical-specific profiles. Toxicol. Sci. 2002, 67:219-231.
49. Hayashi H., Kondo H., Masumura K., Shindo Y., Nohmi T. Novel transgenic rat for in vivo genotoxicity assays using 6-thioguanine and Spi- selection. Environ. Mol. Mutagen. 2003, 41(4):253-259.
50. Heijne W.H., Kienhuis A.S., van Ommen B., Stierum R.H., Groten J.P. Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology. Expert. Rev. Proteomics 2005, 2:767-780.
51. Heller K., Roschenthaler Inhibition of protein synthesis in Streptococcus faecalis by ochratoxin A. Can. J. Microbiol. 1978, 24:467-472.
52. Hibi D., Kijima A., Kuroda K., Suzuki Y., Ishii Y., Jin M., Nakajima M., Sugita-Konishi Y., Yanai T., Nohmi T., Nishikawa A., Umemura T. Molecular mechanisms underlying ochratoxin A-induced genotoxicity: global gene expression analysis suggests induction of DNA double-strand breaks and cell cycle progression. J. Toxicol. Sci. 2013, 38(1):57-69.
53. Hu T., Gibson D.P., Carr G.J., Torontali S.M., Tiesman J.P., Chaney J.G., Aardema M.J. Identification of a gene expression profile that discriminates indirect-acting genotoxins and direct-acting genotoxins. Mutat. Res. 2004, 549:5-27.
54. Hundhausen C., Boesch-Saadatmandi C., Matzner N., Lang F., Blank R., Wolffram S., Blaschek W., Rimbach G. Ochratoxin a lowers mRNA levels of genes encoding for key proteins of liver cell metabolism. Cancer Genomics Proteomics 2008, 5:319-332.
55. IARC Some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins. IARC Monogr. Eval. Carcinogenic Risks Hum. 1993, 56:489-521.
56. IARC Chemical agents and related occupations. IARC Monogr. Eval. Carcinogenic Risks Hum. 2012, 100F:225-244.
57. Jennen D.G., Magkoufopoulou C., Ketelslegers H.B., van Herwijnen M.H., Kleinjans J.C., van Delft J.H. Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol. Sci. 2010, 115:66-79.
58. Jennings P., Weiland C., Limonciel A., Bloch K.M., Radford R., Aschauer L., McMorrow T., Wilmes A., Pfaller W., Ahr H.J., Slattery C., Lock E.A., Ryan M.P., Ellinger-Ziegelbauer H. Transcriptomic alterations induced by Ochratoxin A in rat and human renal proximal tubular in vitro models and comparison to a rat in vivo model. Arch. Toxicol. 2012, 86:571-589.
59. Kamp H., Eisenbrand G., Schlatter J., Wurth K., Janzowski C. Ochratoxin A: induction of (oxidative) DNA damage, cytotoxicity and apoptosis in mammalian cell lines and primary cells. Toxicology 2005, 206:413-425.
60. Kienhuis A.S., Bessems J.G., Pennings J.L., Driessen M., Luijten M., van Delft J.H., Peijnenburg A.A., van der Ven L.T. Application of toxicogenomics in hepatic systems toxicology for risk assessment: acetaminophen as a case study. Toxicol. Appl. Pharmacol. 2011, 250:96-107.
61. Konrad I., Roschenthaler R. Inhibition of phenylalanine tRNA synthetase from Bacillus subtilis by ochratoxin A. FEBS Lett. 1977, 83:341-347.
62. Kuiper-Goodman T. Risk assessment of ochratoxin A: an update. Food Addit. Contam. 1996, 13(Suppl.):53-57.
63. Kuiper-Goodman T. Risk assessment and risk management of mycotoxins in food. Mycotoxins in Food. Detection and Control 2004, 3-31. CRC Press LLC, Boca Raton (FL). N. Magan, M. Olsen (Eds.).
64. Kuiper-Goodman T., Scott P.M. Risk assessment of the mycotoxin ochratoxin A. Biomed. Environ. Sci. 1989, 2:179-248.
65. Kuiper-Goodman T., Hilts C., Billiard S.M., Kiparissis Y., Richard I.D., Hayward S. Health risk assessment of ochratoxin A for all age-sex strata in a market economy. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 2010, 27(2):212-240.
66. Lancaster M.A., Schroth J., Gleeson J.G. Subcellular spatial regulation of canonical Wnt signalling at the primary cilium. Nat. Cell Biol. 2011, 13(6):700-707.
67. Lock E.A., Hard G.C. Chemically induced renal tubule tumors in the laboratory rat and mouse: review of the NCI/NTP database and categorization of renal carcinogens based on mechanistic information. Crit. Rev. Toxicol. 2004, 34:211-299.
68. Luhe A., Hildebrand H., Bach U., Dingermann T., Ahr H.J. A new approach to studying ochratoxin A (OTA)-induced nephrotoxicity: expression profiling in vivo and in vitro employing cDNA microarrays. Toxicol. Sci. 2003, 73:315-328.
69. Magkoufopoulou C., Claessen S.M., Jennen D.G., Kleinjans J.C., van Delft J.H. Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis 2011, 26:593-604.
70. Mally A. Ochratoxin A and mitotic disruption: mode of action analysis of renal tumor formation by ochratoxin A. Toxicol. Sci. 2012, 127:315-330.
71. Mally A., Dekant W. Mycotoxins and the kidney: modes of action for renal tumor formation by ochratoxin A in rodents. Mol. Nutr. Food Res. 2009, 53:467-478.
72. Mally A., Decker M., Bekteshi M., Dekant W. Ochratoxin A alters cell adhesion and gap junction intercellular communication in MDCK cells. Toxicology 2006, 223:15-25.
73. Mantle P., Kulinskaya E., Nestler S. Renal tumourigenesis in male rats in response to chronic dietary ochratoxin A. Food Addit. Contam. 2005, 22(Suppl. 1):58-64.
74. Marin-Kuan, M., Ehrlich, V., Delatour, T., Cavin, C., Schilter, B., 2011. Evidence for a role of oxidative stress in the carcinogenicity of ochratoxin a. J Toxicol. in press.
75. Marin-Kuan M., Nestler S., Verguet C., Bezencon C., Piguet D., Mansourian R., Holzwarth J., Grigorov M., Delatour T., Mantle P., Cavin C., Schilter B. A toxicogenomics approach to identify new plausible epigenetic mechanisms of ochratoxin a carcinogenicity in rat. Toxicol. Sci. 2006, 89:120-134.
76. Marin-Kuan M., Nestler S., Verguet C., Bezenon C., Piguet D., Delatour T., Mantle P., Cavin C., Schilter B. MAPK-ERK activation in kidney of male rats chronically fed ochratoxin A at a dose causing a significant incidence of renal carcinoma. Toxicol. Appl. Pharmacol. 2007, 224:174-181.
77. Marin-Kuan M., Cavin C., Delatour T., Schilter B. Ochratoxin A carcinogenicity involves a complex network of epigenetic mechanisms. Toxicon 2008, 52:195-202.
78. Mathijs K., Brauers K.J., Jennen D.G., Lizarraga D., Kleinjans J.C., van Delft J.H. Gene expression profiling in primary mouse hepatocytes discriminates true from false-positive genotoxic compounds. Mutagenesis 2010, 25:561-568.
79. Minowa Y., Kondo C., Uehara T., Morikawa Y., Okuno Y., Nakatsu N., Ono A., Maruyama T., Kato I., Yamate J., Yamada H., Ohno Y., Urushidani T. Toxicogenomic multigene biomarker for predicting the future onset of proximal tubular injury in rats. Toxicology 2012, 297:47-56.
80. National Toxicology Program (NTP) Toxicology and carcinogenesis studies of ochratoxin A (CAS No 303-47-9) in F344/N rats (gavage studies). Natl. Toxicol. Program Tech. Rep. Ser. 1989, 358:1-142.
81. National Toxicology Program (NTP), 2011. Report on carcinogens. 12th ed.
82. Newton R.K., Aardema M., Aubrecht J. The utility of DNA microarrays for characterizing genotoxicity. Environ. Health Perspect. 2004, 112:420-422.
83. Nuwaysir E.F., Bittner M., Trent J., Barrett J.C., Afshari C.A. Microarrays and toxicology: the advent of toxicogenomics. Mol. Carcinog. 1999, 24:153-159.
84. O'Brien E., Heussner A.H., Dietrich D.R. Species-, sex-, and cell type-specific effects of ochratoxin A and B. Toxicol. Sci. 2001, 63:256-264.
85. Okuyama H., Endo H., Akashika T., Kato K., Inoue M. Downregulation of c-MYC protein levels contributes to cancer cell survival under dual deficiency of oxygen and glucose. Cancer Res. 2010, 70:10213-10223.
86. Olsen, M., Thorup, I., Knudsen, I., Larsen, J.J., Hald, B., Olsen, J., 1991. Health evaluation of ochratoxin A in food products. Number 545. Copenhagen (Denmark): Nordic Council of Ministers.
87. Patil R.D., Dwivedi P., Sharma A.K. Critical period and minimum single oral dose of ochratoxin A for inducing developmental toxicity in pregnant Wistar rats. Reprod. Toxicol. 2006, 22:679-687.
88. Paules R.S., Aubrecht J., Corvi R., Garthoff B., Kleinjans J.C. Moving forward in human cancer risk assessment. Environ. Health Perspect. 2011, 119:739-743.
89. Pfohl-Leszkowicz A., Manderville R.A. Ochratoxin A: an overview on toxicity and carcinogenicity in animals and humans. Mol. Nutr. Food Res. 2007, 51:61-99.
90. Pfohl-Leszkowicz A., Manderville R.A. An update on direct genotoxicity as a molecular mechanism of ochratoxin a carcinogenicity. Chem. Res. Toxicol. 2012, 25:252-262.
91. Pfohl-Leszkowicz A., Pinelli E., Bartsch H., Mohr U., Castegnaro M. Sex- and strain-specific expression of cytochrome P450s in ochratoxin A-induced genotoxicity and carcinogenicity in rats. Mol. Carcinog. 1998, 23:76-85.
92. Rached E., Hard G.C., Blumbach K., Weber K., Draheim R., Lutz W.K., Ozden S., Steger U., Dekant W., Mally A. Ochratoxin A: 13-week oral toxicity and cell proliferation in male F344/n rats. Toxicol. Sci. 2007, 97:288-298.
93. Rached E., Pfeiffer E., Dekant W., Mally A. Ochratoxin A: apoptosis and aberrant exit from mitosis due to perturbation of microtubule dynamics?. Toxicol. Sci. 2006, 92:78-86.
94. Radford R., Slattery C., Jennings P., Blaque O., Pfaller W., Gmuender H., Van Delft J., Ryan M.P., McMorrow T. Carcinogens induce loss of the primary cilium in human renal proximal tubular epithelial cells independently of effects on the cell cycle. Am. J. Physiol. Renal. Physiol. 2012, 302:905-916.
95. Reya T., Clevers H. Wnt signalling in stem cells and cancer. Nature 2005, 434(7035):843-850. (Review).
96. Ringot D., Chango A., Schneider Y.J., Larondelle Y. Toxicokinetics and toxicodynamics of ochratoxin A, an update. Chem. Biol. Interact. 2006, 159:18-46.
97. Rumora L., Zanic-Grubisić T. A journey through mitogen-activated protein kinase and ochratoxin A interactions. Arh. Hig. Rada. Toksikol. 2009, 60:449-456.
98. Sauvant C., Holzinger H., Gekle M. Proximal tubular toxicity of ochratoxin A is amplified by simultaneous inhibition of the extracellular signal-regulated kinases 1/2. J. Pharmacol. Exp. Ther. 2005, 313:234-241.
99. Sava V., Reunova O., Velasquez A., Harbison R., Sanchez-Ramos J. Acute neurotoxic effects of the fungal metabolite ochratoxin-A. Neurotoxicology 2006, 27:82-92.
100. Sava V., Reunova O., Velasquez A., Sanchez-Ramos J. Can low level exposure to ochratoxin-A cause parkinsonism?. J. Neurol. Sci. 2006, 249:68-75.
101. Son W., Kamino K., Lee Y., Kang K. Strain-specific mammary proliferative lesion development following lifetime oral administration of ochratoxin A in DA and Lewis rats. Int. J. Cancer 2003, 105:305-311.
102. Stemmer K., Ellinger-Ziegelbauer H., Ahr H.J., Dietrich D.R. Carcinogen-specific gene expression profiles in short-term treated Eker and wild-type rats indicative of pathways involved in renal tumorigenesis. Cancer Res. 2007, 67:4052-4068.
103. Stemmer K., Ellinger-Ziegelbauer H., Ahr H.J., Dietrich D.R. Molecular characterization of preneoplastic lesions provides insight on the development of renal tumors. Am. J. Pathol. 2009, 175:1686-1698.
104. Taniai E., Yafune A., Hayashi H., Itahashi M., Hara-Kudo Y., Suzuki K., Mitsumori K., Shibutani M. Aberrant activation of ubiquitin D at G(2) phase and apoptosis by carcinogens that evoke cell proliferation after 28-day administration in rats. J. Toxicol. Sci. 2012, 37:1093-1111.
105. Uehara T., Kondo C., Morikawa Y., Hanafusa H., Ueda S., Minowa Y., Nakatsu N., Ono A., Maruyama T., Kato I., Yamate J., Yamada H., Ohno Y., Urushidani T. Toxicogenomic biomarkers for renal papillary injury in rats. Toxicology 2013, 303:1-8.
106. van't Veer L.J., Dai H., van de Vijver M.J., He Y.D., Hart A.A., Mao M., Peterse H.L., van der Kooy K., Marton M.J., Witteveen A.T., Schreiber G.J., Kerkhoven R.M., Roberts C., Linsley P.S., Bernards R., Friend S.H. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415:530-536.
107. van Delft J.H.M., van Agen E., van Breda S.G.J., Herwijnen M.H., Staal Y.C.M., Kleinjans J.C.S. Discrimination of genotoxic and nongenotoxic carcinogens by gene expression profiling. Carcinogenesis 2004, 25:1265-1276.
108. van Delft J.H., Mathijs K., Staal Y.C., van Herwijnen M.H., Brauers K.J., Boorsma A., Kleinjans J.C. Time series analysis of benzo[A]pyrene-induced transcriptome changes suggests that a network of transcription factors regulates the effects on functional gene sets. Toxicol. Sci. 2010, 117:381-392.
109. Wangikar P.B., Dwivedi P., Sharma A.K., Sinha N. Effect in rats of simultaneous prenatal exposure to ochratoxin A and aflatoxin B1. II. Histopathological features of teratological anomalies induced in fetuses. Birth Defects Res. B. Dev. Reprod. Toxicol. 2004, 71:352-358.
110. Wangikar P.B., Dwivedi P., Sinha N., Sharma A.K., Telang A.G. Teratogenic effects in rabbits of simultaneous exposure to ochratoxin A and aflatoxin B1 with special reference to microscopic effects. Toxicology 2005, 215:37-47.
111. Warfel N.A., El-Deiry W.S. P21WAF1 and tumourigenesis: 20 years after. Curr. Opin. Oncol. 2013, 25(1):52-58.
112. Waters M.D., Jackson M., Lea I. Characterizing and predicting carcinogenicity and mode of action using conventional and toxicogenomics methods. Mutat. Res. 2010, 705(3):184-200.
113. WHO (World Health Organisation), 1991. Evaluation of Certain Food Additives and Contaminants (Thirty-seventh report of the Joint FAO/WHO Expert Committee on Food Additives). WHO Technical Report Series, 806.
114. WHO (World Health Organization), 2003. Workshop Report Toxicogenomics and the Risk Assessment of Chemicals for the Protection of Human Health. International Programme on Chemical Safety.
115. WHO (World Health Organisation), 1995. Evaluation of Certain Food Additives and Contaminants (Forty-fourth report of the Joint FAO/WHO Expert Committee on Food Additives). WHO Technical Report Series, 859.
116. WHO (World Health Organisation), 2001. Safety evaluation of certain mycotoxins in food. WHO Food Additives Series, No. 47.
117. WHO (World Health Organisation), 2008. Safety Evaluation of Certain food Additives and Contaminants. WHO Food Additives Series, No. 59.
118. WHO (World Health Organization), 2009. Principles and Methods for the Risk Assessment of Chemicals in Food. International Programme on Chemical Safety. Environmental Health Criteria 240.